Moorthy S. S. Palanki

Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody

Jie Huang, Tetsuya Ishino, Gang Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 118 citations

The Effect of a T Cell-Specific NF-κB Inhibitor on In Vitro Cytokine Production and Collagen-Induced Arthritis

Daniëlle M. Gerlag, Lynn J. Ransone, Paul P. Tak et al. · The Journal of Immunology · 2000 · 97 citations · Full text

Immunology, Immune Regulation, Type Ii Collagen +21

Inhibitors of NF-κB and AP-1 Gene Expression:  SAR Studies on the Pyrimidine Portion of 2-Chloro-4-trifluoromethylpyrimidine-5-[<i>N</i>-(3‘,5‘-bis(trifluoromethyl)phenyl)carboxamide]

Moorthy S. S. Palanki, Paul Erdman, Leah M. Gayo‐Fung et al. · Journal of Medicinal Chemistry · 2000 · 80 citations · Full text

Pharmaceutical Science, Caco-2 Permeability, Pharmacotherapy +16

Immunospecific Reduction of Antioligonucleotide Antibody-Forming Cells with a Tetrakis-oligonucleotide Conjugate (LJP 394), a Therapeutic Candidate for the Treatment of Lupus Nephritis

D. Stephen Charnock‐Jones, P A Barstad, Mark J. Feild et al. · Journal of Medicinal Chemistry · 1995 · 65 citations

Common Carrier, Combinatorial Chemistry, Bioorganic Chemistry +24

Discovery of 3,3‘-(2,4-Diaminopteridine-6,7-diyl)diphenol as an Isozyme-Selective Inhibitor of PI3K for the Treatment of Ischemia Reperfusion Injury Associated with Myocardial Infarction

Moorthy S. S. Palanki, Elena Dneprovskaia, John Doukas et al. · Journal of Medicinal Chemistry · 2007 · 55 citations · Full text

Pi3k Inhibitors, Cardiovascular Pharmacology, Pharmacotherapy +16